CareLabs Q1 2026 Results: Operating Profit Turns Positive, Net Loss Continues
-
Consolidated revenue of 20.5 billion KRW, down 11% YoY (23.1 billion in Q1 2025)
-
Consolidated operating profit of 0.67 billion KRW (Q1 2025: segment profit 2.3 billion, but excluding one-time gain would be a loss)
-
Net loss attributable to parent of 0.61 billion KRW (Q1 2025: net profit of 25.4 billion including real estate sale gain)
-
RCPS liabilities of 9.6 billion KRW, with interest expense of 0.22 billion
-
Land purchase commitments for senior business of 137.1 billion and new HQ construction of 5.3 billion underway
-
One lawsuit as plaintiff (amount 0.57 billion)
-
No dividends for common shareholders (non-controlling dividend of 0.54 billion separate)
KOSDAQ Filing Information
-
Filing: Quarterly Report (2026.03)
-
Company: Carelabs (263700)
-
Submission: Carelabs Co.,Ltd
-
Receipt: 05-15-2026